PreprintCited by 21Cancer, Lipids, and MetabolismCholesterol and Lipid MetabolismProstate Cancer Treatment and Research

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Cholesterol Synthesis Pathway Genes in Prostate Cancer are consistently downregulated when tissue confounding is minimized

Open access

Preprint — published as 10.1186/s12885-018-4373-y · Paper page

Abstract

The relationship between cholesterol and prostate cancer has been extensively studied for decades, where high levels of cellular cholesterol are generally associated with cancer progression and less favorable outcomes. However, the role of in vivo cellular cholesterol synthesis in this process is unclear, and data on the transcriptional activity of cholesterol synthesis pathway genes in tissue from prostate cancer patients are inconsistent. A common problem with cancer tissue data from patient cohorts is the presence of heterogeneous tissue which confounds molecular analysis of the samples. In this study we present a method to minimize systematic confounding from stroma tissue in seven patient cohorts consisting of 1713 prostate cancer and 230 normal tissue samples. When confounding was minimized, differential gene expression analysis over all cohorts showed robust and consistent downregulation of nearly all genes in the cholesterol synthesis pathway. Additional analysis also identified cholesterol synthesis as the most significantly altered metabolic pathway in prostate cancer. This surprising observation is important for our understanding of how prostate cancer cells regulate cholesterol levels in vivo. Moreover, we show that tissue heterogeneity explains the lack of consistency in previous expression analysis of cholesterol synthesis genes in prostate cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/220400

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 64

  1. 10.18632/oncotarget.6370 · DOI
  2. 10.1002/jcb.10724 · DOI
  3. 10.1016/j.bbcan.2013.01.002 · DOI
  4. 10.1016/j.coph.2012.07.006 · DOI
  5. 10.3389/fphar.2013.00119 · DOI
  6. 10.1126/science.290.5497.1721 · DOI
  7. 1984, Progress in Understanding the Ldl Receptor and Hmg-Coa Reductase, 2 Membrane-Proteins That Regulate the Plasma-Cholesterol, J Lipid Res, 25, 1450, 10.1016/S0022-2275(20)34418-7 · DOI
  8. 10.1161/Atvbaha.111.240705 · DOI
  9. 10.1038/bjc.2012.138 · DOI
  10. 10.1073/pnas.94.24.12975 · DOI
  11. 10.1042/BJ20120545 · DOI
  12. 2001, Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2, International journal of cancer. Journal international du cancer, 91, 41, 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2 · DOI
  13. 10.1158/1535-7163.MCT-06-0175 · DOI
  14. 10.1002/pros.20951 · DOI
  15. 10.1371/journal.pone.0008496 · DOI
  16. 10.1016/j.tem.2013.12.007 · DOI
  17. 10.1158/0008-5472.CAN-16-0903 · DOI
  18. 10.1038/35049567 · DOI
  19. 10.1038/ncomms9971 · DOI
  20. 10.1158/0008-5472.CAN-10-0021 · DOI
  21. 10.1073/pnas.2536479100 · DOI
  22. 10.1371/journal.pone.0153727 · DOI
  23. 10.1038/ng1935 · DOI
  24. 10.1073/pnas.1117029108 · DOI
  25. 10.1186/gm433 · DOI
  26. 10.1371/journal.pone.0049831 · DOI
  27. 10.1038/srep16018 · DOI
  28. 10.1074/jbc.R113.479808 · DOI · Paper page
  29. 10.1016/j.ejphar.2011.10.022 · DOI
  30. 10.1038/343425a0 · DOI · Paper page
  31. 10.1172/JCI200216421 · DOI
  32. 10.1016/j.bcp.2013.02.029 · DOI
  33. 10.1210/en.2014-1337 · DOI
  34. 10.1097/01.mco.0000232896.66791.62 · DOI
  35. 10.1016/j.cmet.2014.01.019 · DOI
  36. 10.1007/s10549-013-2473-6 · DOI · Paper page
  37. 10.1186/s12907-015-0008-2 · DOI
  38. 10.1186/1746-1596-9-78 · DOI
  39. 10.1186/1471-2407-10-125 · DOI
  40. 10.1038/cr.2008.61 · DOI · Paper page
  41. 2013, LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly, American journal of cancer research, 3, 58
  42. 10.1158/0008-5472.CAN-12-3128 · DOI
  43. 10.2188/jea.Je20130006 · DOI
  44. 10.1016/j.juro.2009.10.046 · DOI
  45. 10.1530/ERC-12-0085 · DOI
  46. 10.1038/modpathol.3800055 · DOI
  47. 10.1038/nature13438 · DOI · Paper page
  48. 1994, Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells, Blood, 84, 2689, 10.1182/blood.V84.8.2689.2689 · DOI
  49. 10.1093/nar/28.1.27 · DOI · Paper page
  50. 10.1158/1078-0432.CCR-11-2929 · DOI
  51. 10.1371/journal.pone.0045178 · DOI
  52. 10.1016/j.ccr.2010.05.026 · DOI
  53. 10.1016/j.cell.2015.10.025 · DOI
  54. 10.1038/nbt.1914 · DOI
  55. 10.1186/gb-2013-14-4-r36 · DOI · Paper page
  56. 10.1093/bioinformatics/btt656 · DOI · Paper page
  57. 10.1186/gb-2014-15-2-r29 · DOI · Paper page
  58. 10.1186/1755-8794-3-8 · DOI
  59. 10.1371/journal.pone.0066855 · DOI
  60. 10.1186/1755-8794-7-50 · DOI
  61. 10.1126/science.1117679 · DOI · Paper page
  62. 10.1214/09-SS051 · DOI
  63. 10.1038/nprot.2008.211 · DOI · Paper page
  64. 10.1002/pros.21260 · DOI

Metadata

Authors
Rye, M. B., Bertilsson, H., Andersen, M. K., Rise, K., Bathen, T. F., Drabløs, F., & Tessem, M.-B.
Affiliations
Norwegian University of Science and Technology (NO)
Corresponding author
Rye, Morten Beck
Venue
BMC Cancer
Publisher
openRxiv
Published
2017-11-17
Volume
18
Issue
1
Pages
478-478
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2769733322
Cited by
21
References
1
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 2
FWCI
0.60
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
  • U.S. Department of Defense (W81XWH-11-1-, W81XWH, W81XWH1110520, W81XWH1110331)
  • Kreftforeningen (100792–2013, 100792, grant100792-2013)
  • Norges Teknisk-Naturvitenskapelige Universitet
  • Helse Midt-Norge
  • National Institutes of Health (W81XWH)
  • National Cancer Institute (R01CA132874, U01CA111275, P50CA069568)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Keywords
prostate cancer, cholesterol synthesis pathway, tissue heterogeneity, prostate stroma, gene downregulation, differential gene expression
MeSH terms
Cholesterol, Humans, Male, Models, Biological, Prostatic Neoplasms, Transcription, Genetic, Reproducibility of Results, Cohort Studies, Down-Regulation, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Stromal Cells, Lipid Metabolism, Biosynthetic Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review